Type 2 diabetes mellitus Trials in Cuernavaca, Mexico
Conditions / Type 2 diabetes mellitus / Cuernavaca, Mexico
Type 2 diabetes mellitus is a medical condition with active clinical research programs worldwide.
16 total trials for this combination
Showing top 10 of 16 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04255433 | A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT03315143 | Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk | TERMINATED | PHASE3 |
| NCT00637273 | A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2) | COMPLETED | PHASE3 |
| NCT00975286 | 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine | COMPLETED | PHASE3 |
| NCT01499082 | Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin | COMPLETED | PHASE3 |
| NCT00484198 | Study of Rivoglitazone in Type 2 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT00631007 | A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator | COMPLETED | PHASE2 |
| NCT03496298 | Effect of Efpeglenatide on Cardiovascular Outcomes | TERMINATED | PHASE3 |
| NCT03351478 | Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin | COMPLETED | PHASE3 |
| NCT02320721 | Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications | COMPLETED | PHASE3 |